Diagnostic health services provide information about the presence, severity, and cause of diseases and other physical ailments in patients. This is increasingly a critical part of the health care system as greater focus is given to early detection and prevention to reduce overall health care costs.

Diagnostic Imaging services in 2012 generated $3bn in revenue in Australia.  Industry Revenue is expected to grow at an average annualised rate of 5% over the next 5 years.

Approximately 70% of all diagnostic imaging services are funded through Medicare through a bulk billing regime.

Demand for diagnostic imaging services is being driven by:

– Continuing strong growth in the Australian health system
– The ageing population of Australia
– A greater focus on early detection and prevention to reduce overall healthcare costs
– A move away from invasive exploratory surgery towards the use of MRI and CT scanning for certain diagnoses.
– Technical improvements and the accuracy and capabilities of imaging techniques.


Why Invest in Capitol Health?

– The largest provider of community based diagnostic imaging in the state with 51 clinics spread across Victoria
– Business model based on bulk billing ensures a steady revenue stream.
– Investment in latest technology with seven government licensed MRI’s in place.
– Proven ability to take market share from competitors in existing markets, which is important given ongoing industry consolidation.
– Strong reputation for high quality service provision with pure exposure to a growing industry.
– Consistent growth in profitability and outperforming competitors


Investor Relations

The Company’s Continuous Disclosure Policy which is available on the Capitol Health website, sets out the Company’s processes regarding interaction with shareholders, media, analysts, investors and the public. Capitol Health commits to dealing fairly, transparently and openly with both current and prospective shareholders and will ensure that it complies with the Continuous Disclosure Policy to ensure that there is no selective disclosure of information.

Shareholders and investors can raise any issues or concerns at any time by contacting the Company by email at or by writing to the Managing Director or Company Secretary at Level 3, 81 Lorimer Street, Docklands, VIC 3008.  Where possible, bearing in mind the Company’s obligations under the Corporations Act, the ASX Listing Rules and the Continuous Disclosure Policy, responses will be provided.